Frank Rimerman Advisors LLC Buys New Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Frank Rimerman Advisors LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 481 shares of the biotechnology company’s stock, valued at approximately $286,000.

Other hedge funds have also modified their holdings of the company. Public Sector Pension Investment Board raised its holdings in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the period. CIBC Asset Management Inc raised its holdings in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the period. Soros Capital Management LLC purchased a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $630,000. Friedenthal Financial raised its holdings in shares of Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in shares of Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after buying an additional 33,869 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This represents a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Barclays restated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC restated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $554.82 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $42.51 billion, a price-to-earnings ratio of 143.36, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business has a 50 day simple moving average of $593.10 and a 200-day simple moving average of $538.04.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.